Catalyst Biosciences Q3 EPS $(1.06) Down From $(0.64) YoY

Catalyst Biosciences (NASDAQ:CBIO) reported quarterly losses of $(1.06) per share. This is a 65.63 percent decrease over losses of $(0.64) per share from the same period last year.

Benzinga · 11/07/2019 14:39

Catalyst Biosciences (NASDAQ:CBIO) reported quarterly losses of $(1.06) per share. This is a 65.63 percent decrease over losses of $(0.64) per share from the same period last year.